| Application no. and date | 07865137.9 (espacenet) (Federated) (European Patent Register), 20071204 | | Patent/reg. no. and date | DK/EP 2121610, 20140402 | | Publication date | 20091125 | | Priority no. and date | US 870851 P, 20061220 | | EP pub. no. and date |
EP 2121610 20091125 | | Effective date | | | Applicant/owner | Eli Lilly & Company, Lilly Corporate Center
Indianapolis, IN 46285, US | | Applicant ref. no. | Apple Y18736/JSD | | Inventor | KOBIERSKI, Michael Edward, 3969 Shadow Hill Court
Greenwood, Indiana 46142, US,
KOPACH, Michael E., 843 Breaside Lane
Greenwood, Indiana 46143, US,
CHEN, Pingyun, 105 Westchester Place
Chapel Hill, North Carolina 27514, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | C07D 213/53 (2006.01) , C07D 401/14 (2006.01) | | Title | HIDTIL UKENDT MELLEMPRODUKT OG FREMGANGSMÅDE, SOM ER ANVENDELIGE VED FREMSTILLING AF {2-[1-(3,5-BIS-TRIFLUORMETHYL-BENZYL)-5-PYRIDIN-4-YL-1H-[1,2,3]TRIAZOL-4-YL]-PYRIDIN-3-YL}-(2-CHLORPHENYL)-METHANON | | Int. application no. | US2007086319 | | Int. publication no. | WO2008079600 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
